Apollo-backed Covis to buy AMAG Pharmaceuticals
Covis, which is backed by Apollo Global Management, has agreed to acquire AMAG Pharmaceuticals for $13.75 per share in cash.
1 October 2020•4 mins read
Covis, which is backed by Apollo Global Management, has agreed to acquire AMAG Pharmaceuticals for $13.75 per share in cash.
Walter Capital Partners takes significant stake in Quebec educational games maker Passe-Temps
3 hours ago · 1 min read
Truelink Capital’s GES buys CSG Creative from National Trade Productions
3 hours ago · 2 mins read
MPE Partners’ Intermatic adds outdoor lighting-control products maker Sun-Tech
3 hours ago · 2 mins read
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
4 hours ago · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
4 hours ago · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
4 hours ago · 1 min read
PE targets identity security as AI transforms threats: 6 deals
6 hours ago · 3 mins read
